Israel Englander Zentalis Pharmaceuticals, Inc. Transaction History
Millennium Management LLC
- $175 Billion
- Q1 2025
A detailed history of Israel Englander (Millennium Management LLC) transactions in Zentalis Pharmaceuticals, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 3,069,514 shares of ZNTL stock, worth $4.02 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,069,514
Previous 957,563
220.55%
Holding current value
$4.02 Million
Previous $2.9 Million
68.22%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding ZNTL
# of Institutions
139Shares Held
60.5MCall Options Held
7.9KPut Options Held
42.5K-
Matrix Capital Management Company, LP Waltham, MA14MShares$18.3 Million6.94% of portfolio
-
Black Rock Inc. New York, NY4.82MShares$6.31 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.26MShares$4.27 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA2.67MShares$3.5 Million0.01% of portfolio
-
Decheng Capital Management Iii (Cayman), LLC2.1MShares$2.75 Million23.31% of portfolio
About Zentalis Pharmaceuticals, Inc.
- Ticker ZNTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,983,600
- Market Cap $74.6M
- Description
- Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...